Use filters to refine the search results.
Results 1-5 of 5
|1-Jul-2017||Does global drug innovation correspond to burden of disease? The neglected diseases in developed and developing countries||Miraldo, M; Barrenho, E; Smith, P|
|9-Oct-2013||The determinants of attrition in drug development: a duration analysis||Barrenho, E; Smith, PC; Miraldo, M|
|1-Mar-2021||The importance of surgeons and their peers in adoption and diffusion of innovation: an observational study of laparoscopic colectomy adoption and diffusion in England||Barrenho, E; Miraldo, M; Propper, C; Walsh, B; , et al|
|1-Jun-2022||Inequities in cancer drug development in terms of unmet medical need||Barrenho, E; Halmai, R; Miraldo, M; Tzintzun, I; Ali, SR, et al|
|19-May-2022||The impact of the priority review voucher on research and development for tropical diseases||Aerts, C; Barrenho, E; Miraldo, M; Sicuri, E|